Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - BMS
Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
rilvegostomig (AZD2936) - AstraZeneca
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT07720284
 
Jul 23, 2026
 
Prev Next